Diversified End MarketsServing cosmetics, pharmaceuticals and industrial applications gives durable revenue diversification across less-correlated end markets. This reduces dependence on any single cycle, supports cross-selling of specialty ingredients, and preserves long-term demand from structural beauty and healthcare trends.

Recent Revenue ExpansionA 17% year-over-year revenue increase to 2025 and multi-year top-line expansion reflect rising product adoption and market penetration. Sustained revenue growth supports economies of scale, improves bargaining power with suppliers, and provides a base to invest in R&D and margin improvement over the medium term.

Strong Operating Cash GenerationOperating cash flow well above net income indicates core operations generate cash reliably, enabling working-capital funding and servicing interest despite accounting profit volatility. This operational cash strength is a durable buffer for reinvestment or gradual deleveraging if managed alongside capex and receivables.

Bears Say

High LeverageA debt-to-equity ratio of 2.56 and low equity ratio signal material leverage, constraining financial flexibility. High indebtedness raises refinancing and interest-rate sensitivity, limiting the company’s ability to fund strategic investments or absorb demand shocks without additional capital or aggressive cash conversion.

Thin Net MarginsLow gross and especially net margins leave little cushion for cost inflation or pricing pressure. Modest EBIT/EBITDA margins limit internal funding for growth and make returns highly sensitive to raw-material cost swings, impairing long-term ability to finance innovation or absorb competitive pricing moves.

Negative Free Cash FlowNegative free cash flow despite strong operating cash indicates capex, working capital, or other outflows are consuming cash. Persistent FCF deficits force reliance on debt or equity financing, exacerbating leverage and reducing ability to sustain dividends or fund strategic projects without corrective operational or capital allocation changes.

4920 FAQ

What was Nippon Shikizai, Inc.’s price range in the past 12 months?

Nippon Shikizai, Inc. lowest stock price was ¥898.00 and its highest was ¥1265.00 in the past 12 months.

What is Nippon Shikizai, Inc.’s market cap?

Nippon Shikizai, Inc.’s market cap is ¥2.28B.

When is Nippon Shikizai, Inc.’s upcoming earnings report date?

Nippon Shikizai, Inc.’s upcoming earnings report date is Apr 13, 2026 which is in 36 days.

How were Nippon Shikizai, Inc.’s earnings last quarter?

Nippon Shikizai, Inc. released its earnings results on Jan 14, 2026. The company reported ¥80.85 earnings per share for the quarter, beating the consensus estimate of N/A by ¥80.85.

Is Nippon Shikizai, Inc. overvalued?

According to Wall Street analysts Nippon Shikizai, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Nippon Shikizai, Inc. pay dividends?

Nippon Shikizai, Inc. pays a Annually dividend of ¥30 which represents an annual dividend yield of 1.72%. See more information on Nippon Shikizai, Inc. dividends here

What is Nippon Shikizai, Inc.’s EPS estimate?

Nippon Shikizai, Inc.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Nippon Shikizai, Inc. have?

Nippon Shikizai, Inc. has 2,099,376 shares outstanding.

What happened to Nippon Shikizai, Inc.’s price movement after its last earnings report?

Nippon Shikizai, Inc. reported an EPS of ¥80.85 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.667%.

Which hedge fund is a major shareholder of Nippon Shikizai, Inc.?

Currently, no hedge funds are holding shares in JP:4920

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Nippon Shikizai, Inc.

Nippon Shikizai, Inc. researches and develops, manufactures, and sells cosmetics in Japan and internationally. The company offers lip products, such as lipsticks, and lip liners and glosses; eye products, including eye shadows, mascaras, eye liners, and eyebrow make-up products; and facial products comprising foundations, concealers, loose powders, blushes, and highlighters. It also provides skin care products, such as sunscreen and whitening products, scrubs, masks, and cleansers. The company was founded in 1930 and is headquartered in Tokyo, Japan.